In Review: House Bill 192 – relating to minimum reimbursements, decline to dispense, prohibit retaliation, specialty drug labeling prohibitions, will receive a hearing on November 4 at 9:30 A.M. This is the fourth hearing, with no testimony, and a possible amendment introduction/adoption. We expect an amendment to be introduced at this time. You can view this amendment by clicking here. Additionally, SB 207 – relating to copay accumulators will have an opposition hearing on Tuesday, November 4 at 4:00 P.M. PCMA will be testifying in opposition.

Also, PCMA has a meeting with Representative Kellie Deeter (R) and BlinkRx about potentially adding an amendment to HB 229. You can view the amendment language below or by clicking here.

Finally, Lucia Lebens, PCMA’s Chief Government Affairs Officer, will be participating in a panel discussion at the 2025 Healthcare Transformation Summit on Thursday, November 6, from 12:45 P.M. to 1:45 P.M., focusing on Navigating Federal Health Reforms: From Most Favored Nation to Market Disruption & The Big Beautiful Bill.

If you have any questions, please contact Sean Stephenson at sstephenson@pcmanet.org.